Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions

    Pharmaceuticals, Vol. 16, Núm. 11

  2. Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 396, Núm. 6, pp. 1211-1222

  3. Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  4. Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach

    Pharmaceuticals, Vol. 16, Núm. 12

  5. Direct detection of alpha satellite DNA with single-base resolution by using abasic Peptide Nucleic Acids and Fluorescent in situ Hybridization

    Biosensors and Bioelectronics, Vol. 219

  6. Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells

    RSC Medicinal Chemistry, Vol. 14, Núm. 12, pp. 2611-2624

  7. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 8, pp. 2497-2507

  8. Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

    Molecules (Basel, Switzerland), Vol. 28, Núm. 3

  9. Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains

    Pharmaceuticals, Vol. 16, Núm. 10

  10. Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies

    Pharmaceuticals, Vol. 16, Núm. 1

  11. Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  12. In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

    Nano Letters, Vol. 23, Núm. 3, pp. 804-811

  13. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

  14. MAGPIX and FLEXMAP 3D Luminex platforms for direct detection of miR-122-5p through dynamic chemical labelling

    Analyst, Vol. 148, Núm. 22, pp. 5658-5666

  15. Microfluidic systems in extracellular vesicles single analysis. A systematic review

    TrAC - Trends in Analytical Chemistry, Vol. 159

  16. Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors

    Seminars in Immunopathology, Vol. 45, Núm. 1, pp. 43-59

  17. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

    European Journal of Medicinal Chemistry, Vol. 258

  18. New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer

    European Journal of Medicinal Chemistry, Vol. 248

  19. New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action

    European journal of medicinal chemistry, Vol. 246, pp. 115003

  20. Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme

    Purinergic Signalling